← Evidence map

ArticleNature biotechnology2017

First approval in sight for Novartis' CAR-T therapy after panel vote.

Cormac SheridanPubMed ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28787408